Real life outcomes of patients aged ≥75 years old with acute promyelocytic leukemia: experience of the PETHEMA registry

Author:

Salamero Olga1ORCID,Martínez-Cuadrón David23ORCID,Sobas Marta4ORCID,Benavente Celina5,Vives Susana6,De la Serna Javier7ORCID,Pérez-Encinas Manuel8ORCID,Escoda Lourdes9ORCID,Gil Cristina10,Brunet Salut11ORCID,Ramos Fernando12ORCID,Esteve Jordi13ORCID,Amigo Mariluz14,Krsnik Isabel15ORCID,Manso Félix16ORCID,Arias Jesús17,González-Campos José18,Serrano Josefina19ORCID,Oleksiuk Jalanta20,Barrios Manuel21,García-Boyero Raimundo22,Novo Andrés23,Sanz Miguel A.23ORCID,Montesinos Pau23ORCID,

Affiliation:

1. UAB-Medicine Department, Hospital Universitario Vall d’Hebron, VHIO, Barcelona, Spain;

2. Hospital Universitari i Politècnic La Fe, Valencia, Spain;

3. CIBERONC, Instituto Carlos III, Madrid, Spain;

4. Department of Hematology, Blood Neoplasms and Bone Marrow Transplantation, Wroclaw Medical University, Wroclaw, Poland;

5. Hospital Clínico San Carlos, Madrid, Spain;

6. ICO-Hospital Universitari Germans Trias i Pujol, Jose Carreras Research Institute, Badalona, Spain;

7. Hospital 12 de Octubre, Madrid, Spain;

8. Hospital Clínico Universitario, Santiago de Compostela, Spain;

9. Hospital Joan XXIII, Tarragona, Spain;

10. Hospital General de Alicante, Alicante, Spain;

11. Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain;

12. Hospital Universitario de León, León, Spain;

13. Hospital Clinic, Barcelona, Spain;

14. Hospital Morales Meseguer, Murcia, Spain;

15. Hospital Puerta del Hierro, Madrid, Spain;

16. Hospital General de Albacete, Albacete, Spain;

17. Hospital Universitario Lucus Augusti, Lugo, Spain;

18. Hospital Universitario Virgen del Rocío, Sevilla, Spain;

19. Hospital Reina Sofía, Córdoba, Spain;

20. Medical University of Bialystok, Bialystok, Poland;

21. Hospital Regional Universitario Carlos Haya, Málaga, Spain;

22. Hospital General de Castellón, Castellón, Spain;

23. Hospital Universitari Son Espases, Palma, Spain

Funder

FEDER Funds

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3